iwNHL 2017 | iwNHL 2017: T-cell lymphomas, Hodgkin’s lymphoma, immunotherapy and epigenetics
John Gribben, MD, DSc, FRCPath, FMed Sci at Barts Cancer Institute, London, UK joined by Francesco D’Amore, MD, PhD at Aarhus University, Aarhus, Denmark and Steve Ansell, MD, PhD at Mayo Clinic, Rochester, MN share the highlights of the first day of the 2017 International Workshop on Non-Hodgkin Lymphoma, held in Vancouver, BC, Canada. Some of the topics discussed include T-cell lymphomas, immunotherapy, Hodgkin lymphoma and the epigenetics of lymphoma. This video was supported by Janssen Pharmaceuticals (a Johnson & Johnson Company) through an unrestricted educational grant to Magdalen Medical Publishing. The company had no influence on the production of this content.
Get great new content delivered to your inboxSign up